Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds.

The toxic equivalency factor (TEF) method has been used to characterize the toxicity of human mixtures of dioxin-like compounds and is being considered for use with other classes of potentially toxic agents. TEFs are estimated by examining the relative potencies of the various congeners for a series of biological and toxicological effects. In this paper, we consider changes in activity for two enzymes, cytochrome P450 1A1 (CYP1A1)-associated 7-ethoxyresorufin-O-deethylase (EROD) and CYP1A2-associated acetanilide-4-hydroxylase (A4H) activity, resulting from exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 3,3',4,4',5-pentachlorobiphenyl (PCB), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) or a mixture of these agents. The ratio of median effective dose (ED50) is one way to estimate the relative potencies, especially for gene expression and protein endpoints. ED50's were estimated with a nonlinear regression model in which dose-related changes in mean responses are described by a Hill function. ED50's along with other model parameters were estimated by fitting this model to a given data set. Significant differences in estimated model parameters were tested by likelihood ratio methods. The estimated parameters indicated that congener-specific dose-response shapes were significantly different, that additivity failed for these congeners, and that the ratios of ED50's did not predict the response seen for the mixture. These results indicate that for some biological responses, the use of a single relative potency factor (RPF) is not appropriate for the comparison of the dose response behavior of different dioxin-like congeners.

[1]  S. Safe,et al.  Comparative Potencies of Aroclors 1232, 1242, 1248, 1254, and 1260 in Male Wistar Rats—Assessment of the Toxic Equivalency Factor (TEF) Approach for Polychlorinated Biphenyls (PCBs) , 1993 .

[2]  Richard E. Peterson,et al.  Human risk assessment and TEFs , 2000, Food additives and contaminants.

[3]  P. Furst,et al.  Exposure of populations to dioxins and related compounds , 2000, Food additives and contaminants.

[4]  Safe,et al.  Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. , 1998, Environmental health perspectives.

[5]  Y. Kikuchi,et al.  Health effects of chronic exposure to polychlorinated dibenzo-P-dioxins (PCDD), dibenzofurans (PCDF) and coplanar PCB (Co-PCB) of municipal waste incinerator workers. , 2000, Journal of epidemiology.

[6]  A. John Bailer,et al.  Equivalence of concentration–response relationships in aquatic toxicology studies: Testing and implications for potency estimation , 1997 .

[7]  S. Safe,et al.  Immunosuppressive activity of polychlorinated biphenyl mixtures and congeners: nonadditive (antagonistic) interactions. , 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[8]  Bailer Aj,et al.  A measure of tumorigenic potency incorporating dose-response shape. , 1993 .

[9]  S. Safe,et al.  Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). , 1990, Critical reviews in toxicology.

[10]  K. Jones,et al.  Human exposure to PCDD/Fs in the UK: the development of a modelling approach to give historical and future perspectives. , 2000, Environment international.

[11]  A. Brouwer,et al.  Effects of subchronic exposure to complex mixtures of dioxin-like and non-dioxin-like polyhalogenated aromatic compounds on thyroid hormone and vitamin A levels in female Sprague-Dawley rats. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  T. Brubaker,et al.  Nonlinear Parameter Estimation , 1979 .

[13]  L. Birnbaum,et al.  Toxicity equivalency factors for PCBs? , 1991, Quality assurance.

[14]  L Edler,et al.  Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessment. , 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[15]  M. DeVito,et al.  Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls. , 2000, Toxicology and applied pharmacology.

[16]  D. Barnes Toxicity equivalents and EPA's risk assessment of 2,3,7,8-TCDD. , 1991, The Science of the total environment.

[17]  Paul D. Jones,et al.  Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs): implications for risk assessment. , 1998, Critical reviews in toxicology.

[18]  The trouble with TEFs. , 1999 .

[19]  M. DeVito,et al.  Use of toxic equivalency factors for risk assessment for dioxins and related compounds. , 1995, Toxicology.

[20]  J. Michalek,et al.  Serum dioxin and cognitive functioning among veterans of Operation Ranch Hand. , 2001, Neurotoxicology.

[21]  T. Toyo’oka,et al.  Determination of 4-hydroxy-2-nonenal in primary rat hepatocyte cultures by liquid chromatography with laser induced fluorescence detection. , 1999, Biomedical chromatography : BMC.

[22]  R M Putzrath,et al.  Estimating relative potency for receptor-mediated toxicity: reevaluating the toxicity equivalence factor (TEF) model. , 1997, Regulatory toxicology and pharmacology : RTP.

[23]  I. Momas,et al.  [General population exposure to dioxins, human ubiquitous pollutants]. , 2000, Revue d'epidemiologie et de sante publique.

[24]  O. Päpke,et al.  Polychlorinated dibenzodioxins and dibenzofurans in butter from different states in Australia , 2001, Environmental science and pollution research international.

[25]  G. R. Walsh,et al.  Methods Of Optimization , 1976 .